Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Envoy Medical (COCH) Invested Capital (2022 - 2025)

Envoy Medical's Invested Capital history spans 4 years, with the latest figure at -$12.2 million for Q4 2025.

  • Quarterly results put Invested Capital at -$12.2 million for Q4 2025, up 35.47% from a year ago — trailing twelve months through Dec 2025 was -$12.2 million (up 35.47% YoY), and the annual figure for FY2025 was -$12.2 million, up 35.47%.
  • Invested Capital for Q4 2025 was -$12.2 million at Envoy Medical, down from -$7.7 million in the prior quarter.
  • In the past five years, Invested Capital ranged from a high of $5.0 million in Q3 2023 to a low of -$47.5 million in Q1 2023.
  • The 4-year median for Invested Capital is -$21.5 million (2024), against an average of -$20.8 million.
  • The sharpest move saw Invested Capital soared 119.63% in 2023, then tumbled 1186.14% in 2024.
  • Year by year, Invested Capital stood at -$35.9 million in 2022, then soared by 95.91% to -$1.5 million in 2023, then tumbled by 1186.14% to -$18.8 million in 2024, then surged by 35.47% to -$12.2 million in 2025.
  • According to Business Quant data, Invested Capital over the past three periods came in at -$12.2 million, -$7.7 million, and -$29.9 million for Q4 2025, Q3 2025, and Q2 2025 respectively.